MBX Biosciences, Inc.
corporate_fare Company Profile
MBX Biosciences, Inc. (NASDAQ:MBX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 26 items for MBX at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- MBX Biosciences Advances Lead Candidate Canvuparatide to Phase 3 for Hypoparathyroidism After Successful FDA Meeting; Receives EU Orphan Drug Status
- MBX Biosciences Secures New Lab Space, Appoints Experienced Interim CFO Amidst Executive Transition
- Major Investor OrbiMed Reduces Stake in MBX Biosciences Below 10%
- MBX Biosciences Raises $87.1M at Premium in ATM Offering, Bolstering R&D Funding
- MBX Biosciences Appoints Experienced Finance Executive Laurie Stelzer as Independent Director and Audit Committee Chair
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$86.97M
Diluted EPS
-$2.38
Op. Cash Flow
-$79.95M
Free Cash Flow
-$81.88M
Operating Income
-$98.06M
Cash & Equivalents
$75.29M
Debt / Equity
0.00×
Shares Outstanding
44.93M sh
Source: 10-K · filed 2026-03-12 · accession 0001193125-26-103121
show_chartPrice Chart
Loading chart...
feed MBX - Filings & News (Page 2)
MBX
Mar 09, 2026, 8:03 AM EDT
Price at Filing:
$29.53
Real-time Price:
$54.99
Change:
+$25.46 (+86%)
Market Cap:
$2.46B
MBX
Feb 27, 2026, 7:54 AM EST
Price at Filing:
$35.80
Real-time Price:
$54.99
Change:
+$19.19 (+54%)
Market Cap:
$2.46B
MBX
Feb 11, 2026, 6:42 PM EST
Price at Filing:
$35.50
Real-time Price:
$54.99
Change:
+$19.49 (+55%)
Market Cap:
$2.46B
MBX
Feb 05, 2026, 4:27 PM EST
Price at Filing:
$36.05
Real-time Price:
$54.99
Change:
+$18.94 (+53%)
Market Cap:
$2.46B
MBX
Jan 22, 2026, 8:04 AM EST
Price at Filing:
$41.60
Real-time Price:
$54.99
Change:
+$13.39 (+32%)
Market Cap:
$2.46B
MBX
Jan 12, 2026, 6:02 AM EST
Price at Filing:
$32.54
Real-time Price:
$54.99
Change:
+$22.45 (+69%)
Market Cap:
$2.46B